Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
NPJ Breast Cancer|September 1, 2021
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibitionDiar Aziz, Neil Portman, Kristine J Fernandez, et al.
Internal Medicine Journal|April 3, 2018
Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical settingBelinda Lee, Ben Tran, Arthur L Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 TrialJonathan M Loree, Anthony Dowers, Dongsheng Tu, et al.
Nature Methods|August 21, 2007
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detectionBrock A Peters, Zhengyan Kan, Dragan Sebisanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2016
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon CancerPradipta Ghosh, Jeanne Tie, Andrea Muranyi, et al.
The Journal of Clinical Investigation|January 5, 2012
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in miceKathryn M Kinross, Karen G Montgomery, Margarete Kleinschmidt, et al.
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic surveyYasushi Yatabe, Keith M Kerr, Ahmad Utomo, et al.
Pageof 7